MedClosure develops proprietary motorized wound and surgical closure devices for three markets. They have developed Fix-A-Cut, a compact automatic device for closing cuts without stitches; EMTClose, a similar motorized device for emergency medical technicians; and SurgClose, a motorized device for closing surgical incisions where immediate closure is needed. The company is seeking $500,000-$1 million in funding to begin operations, develop products, and launch marketing and sales efforts. They believe the products will be highly profitable with gross margins over 90% and potential acquisition values of $50-100 million.

1. MedClosure, Inc.
Innovation in mechanical wound closure and surgical closure devices
Contact
Richard Hunsaker
rehun@cox.net
702-617-4326
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
1

2. Objective
Market unique medical devices that
meet significant unmet needs in the
Consumer, EMT and Surgical/Medical
categories
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
2

3. MedClosure, Inc.
MedClosure, Inc. a Nevada Corporation with unique
proprietary motorized wound/surgical closure products
for three separate markets.
Fix·A·Cut™ a compact automatic device for closing cuts that may
otherwise require stitches.
EMTClose™ a motorized wound closure device engineered for use by
EMS/Paramedics/Military Medics.
SurgClose™ a specialty motorized surgical closure device for use in
unique surgical (ie. foot/ankle) situations where immediate incision
closure may require stretching of the surrounding dermis to
accomodate sutures.
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
3

4. ™ - Opportunity
Fix·A·Cut
•NEED
• There were over 136 million visits to emergency rooms in 2012
• The average ER wait to stitch a cut is several hours
• Many of these cuts can be closed quickly and easily with Fix·A·Cut™
• Hikers, campers, sporting events, playground…first aid kits.
•
•
The Market is wide open.
There are presently no competitors with automatic (motorized) devices
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
4

5. Product -
™
Fix·A·Cut
•Easy to use in emergency situations
1) Remove from sterile bag
2) Remove adhesive covers
3) Position on each side of wound
4) Draw to close, one button
5) Wound closed, pressure applied & bleeding controlled
6) For longer cuts, use more than 1 device
• Features
• Pre Assembled
• High Tech adhesive base
• Durable
• Benefits
• Can be mounted in seconds, saving precious time
• Strong enough to hold in place while transporting patient
• Holds wound closed & applies pressure to stop bleeding
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
5

6. ™
Fix·A·Cut
Motorized
Motorized Closing Device
Anchor
6

7. ™ - Opportunity
EMTClose
•NEED
• Over 3 million people per year are injured in auto accidents
• Over 40,000 Injuries due to Industrial Accidents
• Over 60,000 Injuries due to crime/violence
• Since 2001 66% casualties in Afghanistan are from IEDs
• EMT/Medic priorities at site of incident
• Check breathing
• Stop Bleeding
• Stabilize/Transport
•
•
The Markets is wide open.
There are presently no competitors
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
7

8. Product -
™
EMTClose
• Larger Version of Fix-A-Cut
1) Multiple units may be used
•Easy to use in emergency situations
1) Remove from sterile bag
2) Remove adhesive covers
3) Position on each side of wound
4) Draw to close, one button
5) Wound closed, pressure applied & bleeding controlled
• Features
• Pre Assembled
• High Tech adhesive base
• Durable
• Benefits
• Can be mounted in seconds, saving precious time
• Strong enough to hold in place while transporting patient
• Holds wound closed & applies pressure to stop bleeding
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
8

9. ™
EMTClose
Anchor
Motor Driven Closure
Motorized
Motorized
*Devices are single units. Multiple devices can be used for larger wounds
9

10. ™- Opportunity
SurgClose
•NEED
• A cost effective post surgery motorized closure device that can
be utilized in specialty surgery situations where the postsurgical incision is difficult to close due to tight surrounding skin
•1,600+ Trauma Centers
• 6,000+ Hospitals
• 135,000+ Surgeons
• Currently one major player in this market
• DermaClose (Wound Care Technologies)
• Current sales nearly $200MM per year
• Single use kit sells to hospital/doctor for $700
• SurgClose™
• More user friendly
• Attached with adhesives rather than barbs
• Many times staples not necessary
• Price point nearly 40% less than DermaClose
• Motorized
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
10

11. Product -
™
SurgClose
•Easy to use
1) Remove from sterile bag
2) Remove adhesive covers
3) Position proper sized tabs on each side of incision
4) Position tab with motor in center
5) Lace the line through the tabs
6) Push button on motor to activate closure
1) Continue until incision is closed
7) Once Incision closed: remove SurgClose™ and suture
• Features
• Pre Assembled
• High Tech adhesive base
• Slots for staples
• Durable
• Benefits
• Can be mounted in seconds, saving precious time
• Strong enough to hold, in most cases without staples
• Expedites incision closure process
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
11

12. ™
SurgClose
medical
adhesive on
underside
Indentations
for medical
staples
(if needed)
Top view
Motorized
anchor plate
attaches to skin
12

13. MedClosure Products
•Easy utilization
• No assembly required
• Adhesive base
•many times, staples not necessary
• 510k exempt
• non invasive
• low product liability insurance
• Profitable
• Versatile
• Intellectual Property
• Patented (pending)
• EMTClose™ #61/711,113
• SurgClose™ #61/810,376
• Product cost below $10
• Price points: $19 - Fix∙A∙Cut $49-EMTClose* $425-SurgClose
• Gross margin 90% - 97%
• Net Profit after taxes nearly 60%
*single unit
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
13

14. Sales/Marketing
• Sell through appropriate consumer & medical channels
• Target Markets
• Fix∙A∙Cut
• Direct response marketing, Major retailers
• EMTClose
• EMT/Fire Stations, Municipal Governments, Military
•SurgClose
• Surgical Centers, Hospitals, Emergency Rooms, Surgeons,
Military
• Utilize our current network of sales talent and add as needed
• Sales/Marketing Management Background:
• Over 50 years combined consumer/pharmaceutical/medical experience
• majority in top management
• Key Sales/Marketing Team Players identified, ready to start
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
14

15. Richard Hunsaker - President
Over 30 years in Sales/Marketing in
Consumer/Pharmaceutical/Medical products.
In his 17 years with Colgate Palmolive, Richard
was Director of Sales for the pharmaceutical
division and part of the operating management.
Over 15 years as principal of RH Sales
Consulting, LLC. Extensive experience in
developing and launching new products in
consumer and medical arenas.
Alan Xenakis, MD, ScD, MPH, MS – Chief Medical Officer
As a physician, broadcaster and former CEO, Dr.
Xenakis brings a wealth of knowledge and
energy to the MedCosure Team. At CBS TV in
Boston, Dr. Xenakis was nominated for an
EMMY 13 times and the recipient once. He has
developed, produced and hosted numerous
health related radio and TV programs at
stations across the country…many of which
were syndicated. Dr. Xenakis has a medical
degree from Boston University School of
Medicine and a Master of Public Health from
Harvard University.
Rod Jones – Chief Marketing Officer
Rod has operating his own marketing business
for over 20 years. He has extensive experience
in direct to consumer and retail marketing.
Rod’s experience and insights make him a vital
component to the MedClosure team.
J. Scott Bierly – Director of Sales
Scott has been in pharmaceutical/medical sales
and sales management for over 30 years. He
has extensive experience in training, developing
and managing sales representatives. Most
recently, he was National Sales Manager for the
national drug distributor, Harvard Drug.
15

16. Investment Opportunity
 Capital required: $500,000 - $1 MM
 High ROI
Gross Margin – over 90%
Net Profit (after tax) nearly 60%
 Exit Strategy
Acquisition or Sale 5-8 years
$50MM - $100MM+
10x – 30x plus ROI
Reverse Merger
 Detailed Business Plan Available
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
16

17. Use of Funds
Operation costs (legal, accounting, office)
$75,000 - $100,000
Product Development/Die Production
$100,000 - $125,000
Sales/Marketing (reps, samples, materials)
$100,000 - $125,000
Rent/Packaging (labor)
$50,000
Inventory & Production (assembly/components/sterilization)
$100,000 - $150,000
IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you
do not agree, delete all electronic files and destroy all hard copies with a return notification to rehun@cox.net
17

18. Confidential Non-Disclosure agreement between MedClosure, Inc. (Discloser) & recipient of document (Recipient)
Discloser possesses certain ideas and information relating to a custom and proprietary design that is confidential and proprietary to
Discloser (hereinafter "Confidential Information"); and
WHEREAS the Recipient is willing to receive disclosure of the Confidential Information pursuant to the terms of this Agreement for the purpose of
assisting/consulting, marketing or any scope of the relationship based on this product:
NOW THEREFORE, in consideration for the mutual undertakings of' the Discloser and the Recipient under this Agreement, the parties agree as follows:
I.
Disclosure. Discloser agrees to disclose, and Receiver agrees to receive the Confidential Information.
2. Confidentiality.
2.1 No Use. Recipient agrees not to use the Confidential Information in any way, or to manufacture or test any product embodying Confidential Information
exceptfor the purpose set forth above.
2.2 No Disclosure. Recipient agrees to use its best efforts to prevent and protect the Confidential Information. or any part thereof. from disclosure to any
person other than Recipient's employees having a need for disclosure in connection with Recipient's authorized use of the Confidential Information.
2.3 Protection of Secrecy. Recipient agrees to take all steps reasonably necessary to protect the secrecy of the Confidential Information, and to prevent the
Confidential Information from falling into the public domain or into the possession of unauthorized persons.
3. Limit on Confidential Information. Confidential Information shall not be deemed proprietary and the Recipient shall have no obligation with respect to
such information where the information:(a) was known to Recipient prior to receiving any of the Confidential Information from Discloser;(b) has become
publicly known through no wrongful act of Recipient:(c) was received by Recipient without breach of this Agreement from a third party without restriction
as to the use and disclosure of the information;(d) was independently developed by Recipient without use of the Confidential Information
Ownership of Confidential Information. Recipient agrees that all Confidential Information shall remain the property of Discloser, and that Discloser
may use such Confidential Information for any purpose without obligation to Recipient. Nothing contained herein shall be construed as granting or
implying any transfer of rights to Recipient in the Confidential Information. or any patents or other intellectual property protecting or relating to the
Confidential Information.
Term and Termination. The obligations of this Agreement shall be in effect for a period of two years.
Survival of Rights and Obligations. This Agreement shall be binding upon. inure to the benefit of. and be enforceable by (a) Discloser, its successors, and
assigns; and (b) Recipient. its successors and assigns.
15